Key advance toward treatment for most common adult form of muscular dystrophy
Thursday, November 20, 2008 - 11:56
in Health & Medicine
Scientists in New York are reporting a critical first step toward development of a long-sought drug to treat myotonic muscular dystrophy (MMD), the most common form of muscular dystrophy in adults. MMD affects about 1 in 8,000 people. Their findings are scheduled for publication the recent issue of ACS' weekly Journal of the American Chemical Society...